Navigation Links
BioCryst to Present at the 11th Annual BIO CEO & Investor Conference
Date:2/2/2009

erformance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. These statements reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Some of the factors that could affect the forward-looking statements contained herein include that our belief that many subjects in the Phase 2 clinical trials of peramivir did not receive adequate dosing by intramuscular injection may not be correct, that HHS and the Food & Drug Administration (FDA) may not agree with our analysis, that HHS may further condition, reduce or eliminate future funding of the peramivir program, that ongoing peramivir clinical trials may not be successful, that the peramivir program may not be successful, that the pivotal trial with forodesine HCl in cutaneous T-cell lymphoma (CTCL) may not meet its endpoint, that development and commercialization of forodesine HCl in CTCL may not be successful, that we or our licensees may not be able to enroll the required number of subjects in planned clinical trials of our product candidates and that such clinical trials may not be successfully completed, that BioCryst or its licensees may not commence as expected additional human clinical trials with our product candidates, that our product candidates may not receive required regulatory clearances from the FDA, that ongoing and future preclinical and clinical development may not have positive results, that we or our licensees may not be able to continue future development of our current and future development programs, that our development programs may never result in future product, license or royalty payments being received by BioCryst, that BioCryst may not be able to retain its current pharmaceutical and biotechnology partners for further deve
'/>"/>
SOURCE BioCryst Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. BioCryst Pharmaceuticals to Announce Fourth Quarter and Year End 2008 Financial Results on February 6, 2009
2. BioCryst to Present at the Rodman and Renshaw 10th Annual Healthcare Conference
3. BioCryst Reports Positive Results From a Phase 2 Study of Intravenous Peramivir for Outpatient Influenza
4. BioCryst Pharmaceuticals to Announce First Quarter 2008 Financial Results on May 8, 2008
5. BioCryst to Release Third Quarter 2007 Financial Results on Thursday, November 8, 2007
6. Interleukin Genetics to Present at G-2 Reports Molecular Diagnostic Conference
7. Prescription Drugs: Good Medicine - Bad Behavior; Science Matters Program Explores the Rise in Prescription Drug Abuse Presented by the California Science Center
8. Inverness Medical Innovations to Present at the 2009 UBS Global Healthcare Services Conference on February 10, 2009
9. eResearchTechnology, Inc. to Present at the UBS Global Healthcare Services Conference on February 10, 2009
10. Triple-S Management Corporation to Present at UBS Global Healthcare Services Conference
11. International Medical Interpreter Association Appoints IMIA State Representatives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2015)... NC (PRWEB) May 24, 2015 Scientists ... a paper on air quality compliance issues that may ... American workers. Surviving Mesothelioma has just posted an article ... now. , The group found airborne asbestos levels ... data collected between 1984 and 2011. , “Asbestos compliance ...
(Date:5/24/2015)... Medicx Media Solutions http://www.medicxmedia.com ... Krihak as its head of programmatic strategy and ... expertise and leadership position in the data driven ... , Krihak is an experienced, award-winning agency and ... sales planning teams for mobile platform Jumptap. ...
(Date:5/23/2015)... 2015 Dr. David Benvenuti, an experienced plastic ... a new article to his website that takes ... Benvenuti explained in the fascinating blog, he has recently ... earlobes. , Known as “gauging,” the technique involves placing larger ... Benvenuti said will eventually stretch the holes out to incredible ...
(Date:5/23/2015)... IL (PRWEB) May 23, 2015 A live ... medical equipment from hospitals, surgery centers and other medical facilities ... be sold including endoscopy, lab, radiology, surgery, anesthesia, exam and ... Wednesday, May 27 and Thursday, May 28 starting at 9:00am ... located at 1400 N. 25th Avenue, Melrose Park, IL 60160. ...
(Date:5/22/2015)... Pioneer Millworks, the largest reclaimed wood ... designing with reclaimed wood, introducing their latest reclaimed wood ... Their newest offerings, Vat 35, Reclaimed Teak , ... to America's largest design event. , “Designers, architects, builders, ... anxious to see and feel the variety of wood ...
Breaking Medicine News(10 mins):Health News:New Analysis Finds Too Many Employers Ignored OSHA Asbestos Guidelines, According to Surviving Mesothelioma 2Health News:Medicx Media Solutions Expands Executive Team 2Health News:Dr. Benvenuti, a Plastic Surgeon in Newport Beach, CA, Posts New Article about Repairing Ear Gauges 2Health News:Over 5,200 Lots of Medical Equipment Will Be Sold by Live Auction 2Health News:Pioneer Millworks to Reveal New Design Trends with Reclaimed Wood at Dwell on Design in LA 2Health News:Pioneer Millworks to Reveal New Design Trends with Reclaimed Wood at Dwell on Design in LA 3
... Cerebral palsy (CP) has increased in infants born prematurely ... from Loyola University Health System (LUHS). These findings were ... for Maternal-Fetal Medicine in Chicago. They also were published ... of Obstetrics & Gynecology . , Researchers reported that ...
... Feb. 9 The following is a statement by ... obesity epidemic will require the kind of clear-eyed and compassionate leadership ... Lady stressed, too many of our children attend schools loaded with ... black and Latino children, however, that bleak food landscape extends far ...
... - The incidence of advanced breast cancer diagnosis among ... compared to white women between 1992 and 2004, according ... Research Center. In addition, the disparity in the incidence ... period as rates fell among whites but increased slightly ...
... (CP) has increased in infants born prematurely in the ... University Health System (LUHS). These findings were reported at ... Medicine in Chicago. They also were published in the ... & Gynecology . , Researchers reported that CP is ...
... ... on powerful prescription drugs to treat anxiety disorders. A new self-help book written ... worry. , ... February 9, 2010 -- Over 40 million Americans suffer from anxiety disorders, a figure ...
... of Torsade de Pointes in new scientific statement , ... health-care professionals need to be aware that certain medications ... called Torsade de Pointes (TdP), says a joint scientific ... College of Cardiology. , The rhythm disturbance is associated ...
Cached Medicine News:Health News:Incidence of cerebral palsy on rise in US 2Health News:Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S. 2Health News:Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S. 3Health News:Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S. 4Health News:Incidence of cerebal palsy on rise in United States 2Health News:Social Anxiety and Panic - Alternative Treatment to Drugs and Therapy 2Health News:ICU Patients at Risk for Rare Heart Rhythm Problem 2
(Date:5/21/2015)... 21, 2015 Research and ... of the "Market Assessment of Respiratory Diagnostics ... to their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,This ... imaging diagnostics market in the United ... . The service provides detailed analysis of the ...
(Date:5/21/2015)... 21, 2015  Cardica, Inc. (Nasdaq: CRDC ) today ... Watson , the company,s vice president of operations, was granted ... stock, at a per share exercise price of $0.43, the ... was granted pursuant to Cardica, Inc.,s Inducement Plan, which was ... under Rule 5653(c)(4) of the Nasdaq Global Market for equity ...
(Date:5/21/2015)... YORK , 21. Mai 2015 ... DPRX ), ein Unternehmen für ... auf die Entwicklung und Vermarktung von ... konzentriert, kündigte heute eine wissenschaftliche Posterpräsentation ... Phase-III-Zulassungsstudie des Unternehmens vorstellt, OneStep-1 und ...
Breaking Medicine Technology:United States and Europe Respiratory Diagnostics Market Assessment 2015 2Cardica Announces New Employment Inducement Grant 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 3Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 4Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 5Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 6Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 7
... DIEGO, May 19 DDW 2008 Annual Meeting ... its pivotal trial,demonstrated physician/nurse teams using the SEDASYS(TM) ... in patients undergoing screening and,diagnostic procedures for colorectal ... (EGD). The study -- which will be,presented Tuesday ...
... Replacement Structurally Similar to, Native Bladder by Six Months; Data Presented ... ... Poster Session, ORLANDO, Fla. and EAST NORRITON, Pa., May ... development of,neo-organs and neo-vessels, presented preclinical efficacy data for its,Tengion Neo-Bladder ...
Cached Medicine Technology:Pivotal Study Shows Physician/Nurse Teams Using SEDASYS(TM) System Reduced Risk of Over Sedation With Propofol 2Pivotal Study Shows Physician/Nurse Teams Using SEDASYS(TM) System Reduced Risk of Over Sedation With Propofol 3Pivotal Study Shows Physician/Nurse Teams Using SEDASYS(TM) System Reduced Risk of Over Sedation With Propofol 4Preclinical Data Demonstrate Ability to Regenerate an Entire Bladder With Tengion Neo-Bladder Replacement(TM) 2
... TruFlow™ Oxygen flowmeter with a Lexan®inner calibrated ... calibration and manufacturing defects. A wide range ... needs. Also available with all popular inlet ... and double unit configurations. Our extra large ...
... with a Lexan®inner calibrated flow tube has ... defects. A wide range of configurations are ... with all popular inlet connections, a 50 ... configurations. Our extra large knob coupled with ...
... series of time-tested Timeter® Classic Flowmeters demonstrates ... care providers and patients alike. You can ... see it in the craftsmanship. You can ... year. Every Timeter® Classic Flowmeter is hand-crafted ...
... series of time-tested Timeter® Classic Flowmeters demonstrates ... care providers and patients alike. You can ... see it in the craftsmanship. You can ... year. Every Timeter® Classic Flowmeter is hand-crafted ...
Medicine Products: